Rare Endocrine Disease Treatment Global Market Report 2025

Published Oct 23, 2025

Length 250 Pages

SKU # BRC20492546

Description

Rare Endocrine Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rare endocrine disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for rare endocrine disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rare endocrine disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Biologics; Organic Compounds

2) By Treatment: Hormone Replacement Therapy; Radiotherapy; Surgery; Targeted Therapy; Immunotherapy

3) By Disease: Cushing's Syndrome; Addison's Disease; Acromegaly; Other Diseases

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Direct Sales; Other Distribution Channels

5) By End-User: Hospitals; Specialty Clinics; Research Institutes; Other End-Users

Subsegments:

1) By Biologics: Monoclonal Antibodies; Recombinant Proteins; Enzyme Replacement Therapies; Vaccines

2) By Organic Compounds: Small Molecule Drugs; Peptide-Based Drugs; Steroidal Compounds; Non-Steroidal Compounds

Companies Mentioned: Pfizer Inc.; Bayer AG; AstraZeneca PLC; Eli Lilly and Company; Novo Nordisk A/S; Sandoz Group AG; Alexion Pharmaceuticals Inc.; Ipsen S.A.; Kyowa Kirin Co. Ltd.; BioMarin Pharmaceutical Inc.; Recordati S.p.A.; Camurus AB; EMD Serono Inc.; Corcept Therapeutics Inc.; Ascendis Pharma A/S; Inozyme Pharma Inc.; Spruce Biosciences Inc.; MBX Biosciences Inc.; Crinetics Pharmaceuticals Inc.; Tiburio Therapeutics Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Rare Endocrine Disease Treatment Market Characteristics
3. Rare Endocrine Disease Treatment Market Trends And Strategies
4. Rare Endocrine Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market: 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Rare Endocrine Disease Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Rare Endocrine Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Rare Endocrine Disease Treatment Market Growth Rate Analysis; 5.4. Global Rare Endocrine Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Rare Endocrine Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Rare Endocrine Disease Treatment Total Addressable Market (TAM)
6. Rare Endocrine Disease Treatment Market Segmentation: 6.1. Global Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Biologics; Organic Compounds; 6.2. Global Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hormone Replacement Therapy; Radiotherapy; Surgery; Targeted Therapy; Immunotherapy; 6.3. Global Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Cushing's Syndrome; Addison's Disease; Acromegaly; Other Diseases; 6.4. Global Rare Endocrine Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Direct Sales; Other Distribution Channels; 6.5. Global Rare Endocrine Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospitals; Specialty Clinics; Research Institutes; Other End-Users; 6.6. Global Rare Endocrine Disease Treatment Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Monoclonal Antibodies; Recombinant Proteins; Enzyme Replacement Therapies; Vaccines; 6.7. Global Rare Endocrine Disease Treatment Market, Sub-Segmentation Of Organic Compounds, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Small Molecule Drugs; Peptide-Based Drugs; Steroidal Compounds; Non-Steroidal Compounds
7. Rare Endocrine Disease Treatment Market Regional And Country Analysis: 7.1. Global Rare Endocrine Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Rare Endocrine Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Rare Endocrine Disease Treatment Market: 8.1. Asia-Pacific Rare Endocrine Disease Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Rare Endocrine Disease Treatment Market: 9.1. China Rare Endocrine Disease Treatment Market Overview; 9.2. China Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Rare Endocrine Disease Treatment Market: 10.1. India Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Rare Endocrine Disease Treatment Market: 11.1. Japan Rare Endocrine Disease Treatment Market Overview; 11.2. Japan Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Rare Endocrine Disease Treatment Market: 12.1. Australia Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Rare Endocrine Disease Treatment Market: 13.1. Indonesia Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Rare Endocrine Disease Treatment Market: 14.1. South Korea Rare Endocrine Disease Treatment Market Overview; 14.2. South Korea Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Rare Endocrine Disease Treatment Market: 15.1. Western Europe Rare Endocrine Disease Treatment Market Overview; 15.2. Western Europe Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Rare Endocrine Disease Treatment Market: 16.1. UK Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Rare Endocrine Disease Treatment Market: 17.1. Germany Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Rare Endocrine Disease Treatment Market: 18.1. France Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Rare Endocrine Disease Treatment Market: 19.1. Italy Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Rare Endocrine Disease Treatment Market: 20.1. Spain Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Rare Endocrine Disease Treatment Market: 21.1. Eastern Europe Rare Endocrine Disease Treatment Market Overview; 21.2. Eastern Europe Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Rare Endocrine Disease Treatment Market: 22.1. Russia Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Rare Endocrine Disease Treatment Market: 23.1. North America Rare Endocrine Disease Treatment Market Overview; 23.2. North America Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Rare Endocrine Disease Treatment Market: 24.1. USA Rare Endocrine Disease Treatment Market Overview; 24.2. USA Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Rare Endocrine Disease Treatment Market: 25.1. Canada Rare Endocrine Disease Treatment Market Overview; 25.2. Canada Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Rare Endocrine Disease Treatment Market: 26.1. South America Rare Endocrine Disease Treatment Market Overview; 26.2. South America Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Rare Endocrine Disease Treatment Market: 27.1. Brazil Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Rare Endocrine Disease Treatment Market: 28.1. Middle East Rare Endocrine Disease Treatment Market Overview; 28.2. Middle East Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Rare Endocrine Disease Treatment Market: 29.1. Africa Rare Endocrine Disease Treatment Market Overview; 29.2. Africa Rare Endocrine Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Rare Endocrine Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Rare Endocrine Disease Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Rare Endocrine Disease Treatment Market Competitive Landscape And Company Profiles: 30.1. Rare Endocrine Disease Treatment Market Competitive Landscape; 30.2. Rare Endocrine Disease Treatment Market Company Profiles; 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
31. Rare Endocrine Disease Treatment Market Other Major And Innovative Companies: 31.1. Sandoz Group AG; 31.2. Alexion Pharmaceuticals Inc.; 31.3. Ipsen S.A.; 31.4. Kyowa Kirin Co. Ltd.; 31.5. BioMarin Pharmaceutical Inc.; 31.6. Recordati S.p.A.; 31.7. Camurus AB; 31.8. EMD Serono Inc.; 31.9. Corcept Therapeutics Inc.; 31.10. Ascendis Pharma A/S; 31.11. Inozyme Pharma Inc.; 31.12. Spruce Biosciences Inc.; 31.13. MBX Biosciences Inc.; 31.14. Crinetics Pharmaceuticals Inc.; 31.15. Tiburio Therapeutics Inc.
32. Global Rare Endocrine Disease Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Rare Endocrine Disease Treatment Market
34. Recent Developments In The Rare Endocrine Disease Treatment Market
35. Rare Endocrine Disease Treatment Market High Potential Countries, Segments and Strategies: 35.1 Rare Endocrine Disease Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Rare Endocrine Disease Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Rare Endocrine Disease Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now